Sarah W Baker

US Patent:

8603543, Dec 10, 2013

Filed:

May 2, 2012

Appl. No.:

13/462627

Inventors:

Galen Stucky - Santa Barbara CA, US
Sarah Baker - Pleasanton CA, US
April Sawvel - Santa Barbara CA, US

Assignee:

The Regents of the University of California - Oakland CA

International Classification:

A61K 33/12
A61K 9/70

US Classification:

424684, 424443, 424446, 424447

Abstract:

The present invention relates to hemostatic compositions comprising a mesocellular oxide foam and, optionally, a biologically active agent such as a procoagulant, as well as devices and methods of use to promote blood clotting.

US Patent:

20080199539, Aug 21, 2008

Filed:

Feb 13, 2008

Appl. No.:

12/030779

Inventors:

Sarah Baker - Santa Barbara CA, US
April Sawvel - Santa Barbara CA, US
Galen D. Stucky - Santa Barbara CA, US

International Classification:

A61L 15/14
A61F 13/00

US Classification:

424684, 424445, 602 48

Abstract:

Hemostatic compositions comprising a wet layered clay (e.g., wet kaolin) and, optionally, a zeolite, as well as devices and methods of use to promote blood clotting, are provided.

US Patent:

20090047329, Feb 19, 2009

Filed:

Aug 13, 2008

Appl. No.:

12/191257

Inventors:

Galen Stucky - Santa Barbara CA, US
Sarah Baker - Santa Barbara CA, US
April Sawvel - Santa Barbara CA, US

International Classification:

A61K 9/70
A61L 15/00

US Classification:

424443, 424 9464, 604304, 424489

Abstract:

The present invention relates to hemostatic compositions comprising a mesocellular oxide foam and, optionally, a biologically active agent such as a procoagulant, as well as devices and methods of use to promote blood clotting.

US Patent:

20100209531, Aug 19, 2010

Filed:

Aug 15, 2006

Appl. No.:

11/464825

Inventors:

Galen Stucky - Santa Barbara CA, US
Todd Ostomel - Davis CA, US
Qihui Shi - Goleta CA, US
April Sawvel - Santa Barbara CA, US
Sarah Baker - Pleasanton CA, US

Assignee:

The Regents of the University of California - Oakland CA

International Classification:

A61K 33/42

US Classification:

424603000, 977906000

Abstract:

The invention provides a homogeneous composition comprising a hemostatically effective amount of a charged oxide, wherein the composition has an isoelectric point, as measured in calcium chloride, below 7.3 or above 7.4. Typically, the charged oxide is selected from the group consisting of silaceous oxides, titanium oxides, aluminum oxides, calcium oxides, zinc oxides, nickel oxides and iron oxides. In some embodiments, the composition further comprises a second oxide selected from the group consisting of calcium oxide, sodium oxide, magnesium oxide, zinc oxide, phosphorus oxide and alumina. In a typical embodiment of the invention, the charged oxide is silaceous oxide, the second oxide comprises calcium oxide and the ratio, by molar ratio, of silaceous oxide to calcium oxide is 0.25 to 15. Optionally, the composition further comprises phosphorous oxide. Also described are methods of making and using such compositions.